Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 33 - Antiparasitic agents
Patents for A61P 33 - Antiparasitic agents (21,787)
10/2003
10/08/2003EP1349833A1 Indole and dihydroindole derivatives
10/08/2003EP1349562A2 Inhibiting gs-fdh to modulate no bioactivity
10/08/2003CN1446579A Medicine for treating sexually transmission disease
10/08/2003CN1123341C Liquid propanethiophenyl imidzole for expelling parasites from body of livestock and its preparing process
10/07/2003US6630579 Complex
10/07/2003US6630499 Control of arthropods in animals
10/07/2003US6630313 Phosphatidyl serine receptors and uses thereof
10/02/2003WO2003081238A2 Cytocapacity test
10/02/2003WO2003080620A1 Inhibitors of nucleoside phosphorylases and nucleosidases
10/02/2003WO2003080600A1 Process to obtain dibenzylbutyrolactonic lignans; process to obtain synthetic derivatives from lignanes bearing anti-chagas chemoprophylactic and therapeutical activities
10/02/2003WO2003080582A2 Fredericamycin derivatives
10/02/2003WO2003080107A1 Remedies for protozoan diseases
10/02/2003WO2003080106A1 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003WO2003080102A1 Method of stimulating growth and resistance to diseases of aquatic organisms
10/02/2003WO2003080064A1 Kinase inhibitors
10/02/2003WO2003080058A1 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003080046A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/02/2003WO2003080045A1 A process for isolating artemisinin from artemisia annua
10/02/2003WO2003079981A2 Bioadhesive drug delivery system
10/02/2003WO2003031599A3 Live attenuated salmonella strains for producing vaccines
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002074323A3 Using neural thread proteins to treat tumors and other hyperproliferative disorders
10/02/2003US20030187276 Hydrophobic polyamine analogs and methods for their use
10/02/2003US20030187225 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders
10/02/2003US20030186999 Purine derivatives having, in particular, antiproliferative properties, and their biological uses
10/02/2003US20030186984 Substituted cyclohexane derivatives
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030186980 Skin disorders; parasiticides
10/02/2003US20030186899 Produced by culturing Saccharopolyspora species LW107129 (NRRL 30141); insecticidal and acaricidal activity; useful intermediates for preparing spinosyn analogs
10/02/2003US20030186894 Dry powder compositions having improved dispersivity
10/02/2003US20030186857 Use of 3-position cyclosporin derivatives for hair growth
10/02/2003US20030186370 Comprises nucleotide sequences coding nicotinic-acetylcholine receptor (5-ht3) for use in screening nematocides, insecticides and/or pesticides
10/02/2003US20030186321 Comprises polypeptide having antitumor, immunomodulatory and viricidal activity for treating leukemia, hepatitis and autoimmune diseases
10/02/2003US20030185836 Cryptosporidium sporozoite antigens
10/02/2003US20030185813 Active substance combinations with insecticidal and acaricidal properties
10/02/2003US20030185761 Buccal, polar and non-polar spray or capsule containing drugs for treating pain
10/02/2003CA2761440A1 Fredericamycin derivatives
10/02/2003CA2480034A1 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003CA2477651A1 Kinase inhibitors
10/02/2003CA2474637A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/01/2003EP1348707A1 Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/01/2003EP1347966A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/01/2003EP1347805A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body
10/01/2003EP1097154B1 Substituted benzimidazoles, production and use thereof as agents for combating parasitic protozoas
10/01/2003EP0988310B1 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
10/01/2003EP0871361B1 Agent for combating parasites in farmed fish
10/01/2003EP0662087B1 Method for purifying retinal pigmented epithelium derived neurotrophic factor
10/01/2003CN1446102A Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens
10/01/2003CN1444946A Method for preparing nano-microballons of Avermectins medicine and usage
10/01/2003CN1444926A Bio-adhesiveness drug release system
10/01/2003CN1444925A Long acting injection containing ethyl cellulose for animal
10/01/2003CN1122443C Antiparasitic composition for treating and protecting pets
09/2003
09/30/2003US6627641 Antimalarial naphthylisoquinoline alkaloid derivatives, methods for obtaining such derivatives, and methods of using such antimalarial compounds for the prevention of malaria infections in mammals and for treating mammals with malarial
09/30/2003US6627637 I kappa B kinase inhibitors for treating various disorders including arthritis
09/30/2003US6627626 Antiinflammation agents and antiarthritic agents colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock animals.
09/30/2003CA2133759C Evaluation and treatment of patients with progressive immunosuppression
09/25/2003WO2003078405A1 Parasiticidal agents
09/25/2003WO2003078386A1 Naphthylsemicarbazone, naphthylhydrazone, naphthylthiosemicarbazone, and naphthylthiohydrazone compounds and therapeutic use thereof
09/25/2003WO2003078361A1 Controlling chemical reactions by spectral chemistry and spectral conditioning
09/25/2003WO2003077944A1 Improvements in vaccination
09/25/2003WO2003077832A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes
09/25/2003WO2003077830A2 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives
09/25/2003WO2002097081A3 Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production
09/25/2003WO2002092628A3 Plasmodium falciparum antigens and vaccine and diagnostic uses thereof
09/25/2003US20030181477 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
09/25/2003US20030181476 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof
09/25/2003US20030181467 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same
09/25/2003US20030181451 Use of triazinetrione sulfoxides for controlling coccidioses
09/25/2003US20030181435 Systemic lupus erythematosus therapy
09/25/2003US20030181376 Control of crop pests & animal parasites through direct neuronal uptake
09/25/2003US20030181362 Receptor
09/25/2003US20030180934 Plasminogen-like polynucleotides, polypeptides, and antibodies
09/25/2003US20030180877 Gene therapy; drug screening
09/25/2003US20030180785 Polynucleotide molecules encoding Neospora proteins
09/25/2003US20030180366 Bioadhesive drug delivery system
09/25/2003US20030180328 Forming vaccines; analyzing hemagglutinin, calibration
09/25/2003CA2479676A1 Dexanabinol and dexanabinol analogs regulate inflammation related genes
09/25/2003CA2479315A1 Improvements in vaccination
09/25/2003CA2479211A1 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives
09/25/2003CA2478805A1 Controlling chemical reactions by spectral chemistry and spectral conditioning
09/24/2003EP1345941A1 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors
09/24/2003EP1345931A2 Cysteine protease inhibitors
09/24/2003EP1345902A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/24/2003CN1444481A Protease inhibitors
09/24/2003CN1122035C Antiparasitic artemisinin derivatives, its preparing method and composition and use
09/24/2003CN1121861C Delayed praziquantel bar for dog
09/23/2003US6624172 Imidazonaphthyridines
09/23/2003US6624151 Concerns the uses of said compounds as selective inhibitors of T gamma 9 delta 2 lymphocytes, their uses, for therapeutic purposes.
09/23/2003US6623735 Vaccine containing a thiol protease
09/18/2003WO2003076602A2 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo
09/18/2003WO2003076570A2 Antigens and their use as diagnostics and vaccines against species of plasmodium
09/18/2003WO2003076446A1 Antiparasitic artemisinin derivatives (endoperoxides)
09/18/2003WO2003076425A1 Novel compounds and antimalarials
09/18/2003WO2003076424A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003WO2003075956A2 Use of mixtures of lipopeptides for vaccine production
09/18/2003WO2003075927A1 Pharmaceutical combination of artesunate and mefloquine for therapy of malaria
09/18/2003WO2003075912A1 Artelinic acid-l-lysine salt for treatment of severe and complicated malaria
1 ... 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 ... 218